Advertisement

Advertisement

SE:ACE Stock Latest News

Ascelia Pharma’s Orviglance NDA Accepted by FDA as Cash Runway Extends Beyond 2026 Decision

Company AnnouncementsAscelia Pharma’s Orviglance NDA Accepted by FDA as Cash Runway Extends Beyond 2026 Decision

Ascelia Pharma Deputy CEO and CFO Julie Waras Brogren to Depart for New CEO Role

PremiumCompany Announcements

Ascelia Pharma Deputy CEO and CFO Julie Waras Brogren to Depart for New CEO Role

2M ago

Ascelia Pharma Appoints Nomination Committee Ahead of 2026 AGM

PremiumCompany Announcements

Ascelia Pharma Appoints Nomination Committee Ahead of 2026 AGM

3M ago

Ascelia Pharma Adjusts Share Structure Following Share Saving Program

PremiumCompany Announcements

Ascelia Pharma Adjusts Share Structure Following Share Saving Program

4M ago

Ascelia Pharma Converts Series C Shares to Ordinary Shares for Incentive Program

PremiumCompany Announcements

Ascelia Pharma Converts Series C Shares to Ordinary Shares for Incentive Program

4M ago

FDA Accepts Ascelia Pharma’s Orviglance NDA for Review

PremiumCompany AnnouncementsFDA Accepts Ascelia Pharma’s Orviglance NDA for Review

4M ago

Ascelia Pharma Files Patent for Orviglance, Enhancing Market Protection

Company Announcements

Ascelia Pharma Files Patent for Orviglance, Enhancing Market Protection

4M ago

Ascelia Pharma Advances Orviglance with FDA Submission and Financial Strengthening

Company Announcements

Ascelia Pharma Advances Orviglance with FDA Submission and Financial Strengthening

5M ago

Ascelia Pharma Strengthens Leadership Team for Future Growth

PremiumCompany Announcements

Ascelia Pharma Strengthens Leadership Team for Future Growth

5M ago

Ascelia Pharma Completes SEK 30 Million Directed Share Issue

PremiumCompany Announcements

Ascelia Pharma Completes SEK 30 Million Directed Share Issue

6M ago

Ascelia Pharma Plans SEK 30 Million Directed Share Issue

PremiumCompany Announcements

Ascelia Pharma Plans SEK 30 Million Directed Share Issue

6M ago

Ascelia Pharma Submits NDA for Orviglance to FDA

PremiumCompany Announcements

Ascelia Pharma Submits NDA for Orviglance to FDA

7M ago

Ascelia Pharma Converts Outstanding Convertibles, Extends Cash Runway

PremiumCompany AnnouncementsAscelia Pharma Converts Outstanding Convertibles, Extends Cash Runway

7M ago

Ascelia Pharma Nears NDA Submission for Orviglance

Company Announcements

Ascelia Pharma Nears NDA Submission for Orviglance

7M ago

7ZA Earnings this Week: How Will it Perform?

Pre-Earnings

7ZA Earnings this Week: How Will it Perform?

7M ago

Ascelia Pharma Nears Submission of Orviglance NDA to FDA

PremiumCompany Announcements

Ascelia Pharma Nears Submission of Orviglance NDA to FDA

7M ago

Ascelia Pharma Advances Orviglance Towards FDA Submission

PremiumCompany Announcements

Ascelia Pharma Advances Orviglance Towards FDA Submission

10M ago

Ascelia Pharma AB (7ZA) Q1 Earnings Cheat Sheet

PremiumPre-Earnings

Ascelia Pharma AB (7ZA) Q1 Earnings Cheat Sheet

10M ago

Ascelia Pharma’s AGM: Key Resolutions and Strategic Authorizations

PremiumCompany Announcements

Ascelia Pharma’s AGM: Key Resolutions and Strategic Authorizations

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >